• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/02/2022
Event Type  Injury  
Event Description
It was reported that stent migration occurred.The 80% stenosed target lesion was located in the moderate to severely tortuous and non- to mildly calcified proximal circumflex artery.No lesion preparation was performed.A 4.50 x 16mm synergy xd drug-eluting stent (des) was advanced for treatment.The stent was inflated at 11 atmospheres (atm) for 20 seconds and appeared normal and expanded.The stent was placed; however, the stent shifted distal to the lesion.Another 4.50 x 12mm synergy xd des was advanced to cover the missed lesion and was inflated at 12 atm for 20 seconds.Prior to removal, the balloon was deflated; however, when the physician tried to remove the balloon catheter, there was resistance.The inflation device was checked to confirm it was down and the doctor pulled to get the catheter out.After removal, it was noticed that the stent itself pulled back into the left main artery, and the distal edge of the stent appeared to be not fully expanded and also was now proximal to the lesion.Subsequently, another 5.0x12 synergy xd des was advanced and inflated at 16 atmospheres for 10 seconds to put between the 2 stents and "tacked" everything down.A non-boston scientific balloon catheter was used to post dilate all and the procedure was completed successfully.Intravascular ultrasound confirmed there was no crushed or broken metal or other issues, and the end result was fine.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14504054
MDR Text Key292698591
Report Number2134265-2022-05368
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-